echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Blood: PET-CT guidance consolidates the effects of radiotherapy on long-term prognostication in patients with advanced DLBCL.

    Blood: PET-CT guidance consolidates the effects of radiotherapy on long-term prognostication in patients with advanced DLBCL.

    • Last Update: 2020-09-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The consolidation of radiotherapy (RT) for advanced diffuse large B-cell lymphoma (DLBCL) remains controversial, and clinical routine treatment still uses RT in patients with large initial tumor volume or residual lumps.
    PET-CT is a sensitive way to detect the presence of residual lesions at the end of treatment (EOT).
    has been using PET-guided methods to selectively manage RT in BC since 2005.
    study analyzed EOT-PET data from patients with advanced DLBCL who received at least six courses of treatment with R-CHOP between January 2005 and March 2017.
    have been observed in patients with complete metabolic remission (PET-NEG) and, where feasible, in patients with PET-POS positives.
    723 patients were followed in the middle for 4.3 years: 517 (72%) were PET-NEG and 206 (28%) were PET-ROS.
    3-year progress time (TTP) was 83% vs 56% for PET-NEG and PET-ROS patients, and 87% vs 64% for 3-year overall survival (OS) respectively.
    non-progressive PET-POS patients who received solid radiotherapy (109/206,53%) had a prognostic close proximity to PET-NEG patients, with 3-year TTP and OS estimates of 76% and 80%, respectively.
    of PET-NEG patients with a tumor diameter of 10 cm at the time of diagnosis was no different from that of patients with smaller tumor size, even if RT was not performed.
    , this study shows that patients with advanced DLBCL who have PET-NEG at EOT and who are not treated with RT have good prognostication.
    FDG-PET can reliably guide patients on whether they need solid radiotherapy.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.